Author： Fléchelles Olivier Fowler Robert Jouvet Philippe
Publisher： Informa Healthcare
ISSN： 1478-7210
Source： Expert Review of Anti-Infective Therapy, Vol.11, Iss.6, 2013-06, pp. : 555-563
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Canada was one of the first countries affected by the 2009 influenza H1N1 pandemic with two waves - one from May to June and one from October to December. The 2009 influenza H1N1 pandemic had many unique features when compared with seasonal influenza, including the following: more than half of the affected people were children; asthma was the most significant risk factor for hospital admission; and Aboriginal and pregnant women had a higher risk of hospital admission and complications. Antiviral therapy was widely used but data did not show any effect on the pediatric population. Outbreak spread was possibly promoted from child-child and child-adult contact, and therefore the vaccination campaign targeted the pediatric population and achieved good coverage among young children (57%). Vaccination efficacy was difficult to test because of the vaccination delay. Improvement in models of prevention and treatment are urgently needed to prepare for the possible future pandemics.
Related content
By Mori Toshihiko Morii Mayuko Terada Kojiro Wada Yoshimasa Kuroiwa Yuki Hotsubo Tomoyuki Fuse Shigeto Nishioka Seiko Nishioka Takeshi Tsutsumi Hiroyuki
Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 1, 2011-01 ,pp. :
Access to resources
Recommend
By Van Cleve William C. Hagan Pat Lozano Paula Mangione-Smith Rita
Joint Commission Journal on Quality and Patient Safety, Vol. 37, Iss. 8, 2011-08 ,pp. :
By Okada Takafumi Morozumi Miyuki Matsubara Keita Komiyama Osamu Ubukata Kimiko Takahashi Takashi Iwata Satoshi
Journal of Infection and Chemotherapy, Vol. 17, Iss. 2, 2011-04 ,pp. :